Breaking News

And four, with Johnson & Johnson

The European Medicines Agency authorizes member states to protect their populations with the American vaccine. Easy to store and requiring only one dose, the product will disrupt current vaccination campaigns

Patrick JACQUEMOT

Patrick JACQUEMOT

The European Medicines Agency authorizes member states to protect their populations with the American vaccine. Easy to store and requiring only one dose, the product will disrupt current vaccination campaigns

And four in less than three months. After Pfizer at the end of December, Moderna at the very beginning of 2021 and AstraZeneca at the end of January, Thursday, the European Medicines Agency has just authorized the marketing of the Union the vaccine developed by the Johnson & Johnson laboratory. The first single injection to be thus validated on the territory of the Union.

The European Commission has already purchased 200 million doses, and made an option for another 200 million vials. In fact, in proportion to its population (0.14%), the Grand Duchy would be eligible to receive 280,000 doses of this serum Firstly. A “good news” as the Minister of Health announced the same morning that she had to put aside a whole dubious batch of AstraZeneca vaccines. 4,800 doses of which we do not know if they will one day be likely to enter the vaccination plan started since December 28 in the country.

This decision is an undeniable boost to the EU’s anti-covid vaccination roll-out program, criticized for being slow. Even if nothing says, for the moment that the first doses of Johnson & Johnson can arrive on this side of the Atlantic before the month of April. By then, the EMA might have ruled on the fate to be reserved for other cases. Indeed, three other vaccines are the subject of a “continuous review” by this authority: Novavax, CureVac and the Russian Spoutnik V.

While 48,961 anti-covid doses have already been administered in Luxembourg, on the side of Villa Louvigny, no one hides their relief to see Johnson & Johnson possibly entering the national immunization campaign. Stored in a simple refrigerator, the US vials could be easily distributed to medical offices or pharmacies, with the responsibility then for the white coats to ensure the injection to the general public while respecting the fixed ordering. It will be up to the government council to authorize this possibility or not.

Moreover, the fact that this vaccine requires only one injection (against two with the other validated sera) should make it possible to protect the voluntary population to receive the injection more quickly.


Tags

Related Articles

Back to top button
Close
Close